The Human Genome

Overview of the Human Genome

The human genome is the complete set of genetic information encoded in the DNA of Homo sapiens. It contains approximately 3.2 billion (3.2 × 10⁹) base pairs of DNA in the haploid state (one copy of each chromosome). In the diploid state of most somatic cells, the genome contains approximately 6.4 billion base pairs organized into 46 chromosomes (22 pairs of autosomes + 1 pair of sex chromosomes).

The Human Genome Project (HGP), completed in April 2003, produced the first reference human genome sequence — a monumental collaborative achievement involving laboratories in the United States, United Kingdom, France, Germany, Japan, and China. The HGP cost approximately $2.7 billion and took 13 years. Today, a human genome can be sequenced for approximately $200–500 and the raw data produced in about 24 hours using next-generation sequencing technology — a price reduction of over 10 million-fold in 20 years.

Genome Size and Complexity

Paradoxically, the human genome is neither the largest nor the most gene-dense genome known. The Paris japonica flower has a genome 50× larger than humans (~150 billion base pairs). The relationship between organism complexity and genome size is called the "C-value paradox" — there is no simple correlation. What distinguishes the human genome is not its size but the extraordinary complexity of its gene regulation, splicing diversity, and developmental gene expression programs.

If the DNA in a single human cell were stretched end-to-end, it would be approximately 2 meters long. Yet it is coiled and compacted into a nucleus approximately 6 micrometers in diameter — a compaction ratio of roughly 300,000:1. This extraordinary packaging is achieved through multiple levels of DNA compaction: nucleosome formation (DNA wraps around histone octamers), 30-nm chromatin fiber formation, looping, and chromosome condensation.

Chromosomes and Karyotype

The human genome is organized into 23 pairs of chromosomes in somatic cells — 22 pairs of autosomes (numbered 1–22, roughly in order of decreasing size) and 1 pair of sex chromosomes (XX in females, XY in males). The total diploid chromosome number is 46. Each chromosome consists of a single, continuous, linear DNA molecule associated with proteins (mainly histones).

Human Chromosome Reference Data

Karyotype Analysis

A karyotype is an ordered image of an individual's full complement of chromosomes, typically produced from cultured white blood cells stimulated to divide, arrested in metaphase (when chromosomes are most condensed), and stained with Giemsa or similar dyes to produce characteristic banding patterns (G-bands). Karyotyping allows identification of chromosomal abnormalities including:

• Aneuploidy: Abnormal chromosome number — trisomy 21 (Down syndrome, +21), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), monosomy X (Turner syndrome, 45,X), 47,XXY (Klinefelter syndrome)
• Structural rearrangements: Deletions, duplications, inversions, translocations — e.g., the Philadelphia chromosome t(9;22) in CML
• Mosaicism: Two or more cell populations with different karyotypes in one individual

Protein-Coding Genes

Despite constituting approximately 1.5% of the total genome, protein-coding genes are the primary functional units that have traditionally defined genomics. Current estimates from GENCODE (the reference gene annotation project) identify approximately 19,000–20,000 protein-coding genes in the human genome — remarkably similar to simpler organisms like the nematode worm C. elegans (~20,000 genes) and far fewer than many plant species. The C. elegans comparison challenged the assumption that complexity correlates with gene number.

Human protein-coding genes vary enormously in size:

• Smallest protein-coding genes: Some encode proteins of only ~30–100 amino acids (e.g., histone genes)
• Largest gene: DMD (dystrophin) — 2.4 Mb genomic span, 79 exons, ~14 kb mRNA
• Most transcripts per gene: KCNQ5 has over 30 alternative transcripts
• Gene density: Chromosome 19 has the highest gene density (~23 genes/Mb); chromosomes 13 and 18 are gene-poor

The complexity of the human proteome far exceeds the gene number through alternative splicing — a single gene can produce multiple distinct proteins by including or excluding different exons. The total human proteome is estimated to include over 100,000 distinct protein isoforms. Post-translational modifications (phosphorylation, ubiquitination, glycosylation, etc.) add another layer of functional diversity.

Introns, Exons, and Pre-mRNA Processing

One of the most remarkable features of eukaryotic genes is that the protein-coding information is split into discontinuous segments called exons, separated by non-coding intervening sequences called introns.

Gene Structure

A typical human gene contains:

• Promoter and regulatory elements (5' of the transcription start site)
• 5' UTR (untranslated region in the mRNA, between TSS and start codon AUG)
• Exons — coding sequences that appear in the mature mRNA; average human exon is ~170 bp
• Introns — intervening sequences removed during pre-mRNA splicing; average human intron is ~3,000 bp (can exceed 100 kb)
• 3' UTR (after stop codon — contains signals for polyadenylation and mRNA stability)
• Poly-A tail — added post-transcriptionally to the 3' end

Pre-mRNA Splicing

After transcription, introns are removed from the pre-mRNA by the spliceosome — a large ribonucleoprotein complex containing 5 snRNAs (U1, U2, U4, U5, U6) and over 150 proteins. Splicing recognizes conserved splice site sequences (5' splice site: GU; 3' splice site: AG — the "GT-AG rule") and branch point sequences within the intron. The intron is excised as a lariat structure and degraded.

Alternative Splicing

Alternative splicing allows different exon combinations to be included in the mature mRNA, generating multiple protein isoforms from a single gene. Approximately 95% of multi-exon human genes undergo alternative splicing. Types include: exon skipping (most common, ~39%), alternative 5' or 3' splice site selection, intron retention, and mutually exclusive exon usage. Alternative splicing is regulated by splicing factors (SR proteins, hnRNPs) that bind to exonic/intronic splicing enhancers and silencers.

Non-Coding RNA (ncRNA)

While protein-coding genes were historically the focus of genomics, it is now recognized that the vast majority of the genome is transcribed but most transcripts do not encode proteins. Non-coding RNAs (ncRNAs) include several major classes with distinct biogenesis and functions:

The ENCODE project demonstrated that approximately 80% of the human genome shows biochemical activity (transcription, chromatin modification, protein binding) in at least one cell type — challenging the notion of "junk DNA." However, whether all of this activity represents functional elements remains actively debated.

Repetitive Elements

Approximately 45–50% of the human genome consists of repetitive sequences — transposable elements (mobile genetic elements) and tandem repeats. Far from being uniformly "junk," repetitive elements have profoundly shaped genome evolution and some have been co-opted for regulatory functions.

• LINEs (Long Interspersed Nuclear Elements): ~20% of genome; L1 elements (6 kb) can transpose via RNA intermediate; ~100 L1 elements remain potentially active
• SINEs (Short Interspersed Nuclear Elements): ~13%; Alu elements (~300 bp) are the most abundant — ~1.1 million copies; B2 and MIRs in other mammals
• LTR retrotransposons (HERVs): ~8%; Human Endogenous Retroviruses — ancient retroviral integrations; some HERV-derived proteins have been co-opted (syncytins for placental development)
• DNA transposons: ~3%; currently mostly inactive in humans
• Tandem repeats: Satellite DNA (constitutive heterochromatin, centromeres), microsatellites (STRs, used in forensic DNA profiling), and minisatellites

The Personal Genomics Era

The dramatic drop in sequencing costs has ushered in an era of personal genomics — where an individual's entire genome can be sequenced, analyzed, and interpreted at clinical scale. This revolution is transforming medicine, ancestry research, and our understanding of disease.

Sequencing Technologies

• Whole Genome Sequencing (WGS): Sequences all ~3.2 billion base pairs; detects SNPs, indels, structural variants, CNVs; ~$200–500 for 30× coverage (2026)
• Whole Exome Sequencing (WES): Sequences only the coding exons (~1.5% of genome); ~$200–300; misses non-coding regulatory variants
• SNP Array / Genotyping Chips: Tests 500,000–4 million known variant positions; cost ~$50–200; used in consumer genomics (23andMe, AncestryDNA)
• Long-read sequencing (PacBio, Oxford Nanopore): Reads of 10–100+ kb; resolves complex structural variants, haplotype phasing, repetitive regions

Clinical Applications

• Rare disease diagnosis: WGS/WES solves ~35–40% of previously undiagnosed rare disease cases
• Cancer genomics: Tumor sequencing identifies actionable mutations (EGFR, KRAS, BRCA1/2, PIK3CA) guiding targeted therapy selection
• Pharmacogenomics: CYP2D6, CYP2C19, TPMT, DPYD variants predict drug metabolism and toxicity risk
• Newborn screening: Genomic sequencing replacing biochemical newborn screening panels — identifies hundreds of conditions
• Polygenic risk scores: Aggregate thousands of common variants to predict individual risk for diabetes, coronary artery disease, breast cancer, and other common diseases

Privacy and Ethical Considerations

Genomic data is uniquely identifying — it cannot be de-identified and it reveals information about biological relatives who have not consented. Key ethical issues include: informed consent for secondary uses of genomic data, risk of genetic discrimination (GINA in the US provides some workplace and insurance protection), data security and commercial exploitation of genomic databases, return of incidental findings (variants not related to the indication for testing), and equity in access to genomic medicine.